Left ventricular concentric remodeling rather than left ventricular hypertrophy is related to the insulin resistance syndrome in elderly men

Circulation

Volumn 101, Issue 22, 2000, Pages 2595-2600

  Sundström, Johan ^b,c   Lind, Lars ^b   Nyström, Niklas ^b   Zethelius, Björn ^b   Andrén, Bertil ^b   Hales, C Nicholas ^a   Lithell, Hans O ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b Dept Pub Hlth Caring Sci/Geriat ^*

^c NONE   (Sweden)

Author keywords

Glucose; Hypertrophy; Insulin; Risk factors

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INSULIN;

AGED; AGING; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE MONITORING; ECHOCARDIOGRAPHY; GLUCOSE INTOLERANCE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RISK FACTOR; STROKE;

EID: 0034612297     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.22.2595     Document Type: Article

References (16)

1. Koren MJ, Devereux RB, Casale PN, et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991;114:345-352.
2. Levy D, Garrison RJ, Savage DD, et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322:1561-1566.
3. Bikkina M, Levy D, Evans JC, et al. Left ventricular mass and risk of stroke in an elderly cohort: the Framingham Heart Study. JAMA. 1994; 272:33-36.
4. Ghali JK, Liao Y, Simmons B, et al. The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease. Ann Intern Med. 1992;117:831-836.
5. Ganau A, Devereux RB, Roman MJ, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol. 1992;19:1550-1558.
6. Verdecchia P, Schillaci G, Borgioni C, et al. Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass. J Am Coll Cardiol. 1995;25: 871-878.
7. Majahalme S, Turjanmaa V, Weder A, et al. Blood pressure levels and variability, smoking, and left ventricular structure in normotension and in borderline and mild hypertension. Am J Hypertens. 1996;9:1110-1118.
8. Lind L, Jakobsson S, Lithell H, et al. Relation of serum calcium concentration to metabolic risk factors for cardiovascular disease. BMJ. 1988; 297:960-963.
9. Modan M, Halkin H, Almog S, et al. Hyperinsulinemia: a link between hypertension obesity and glucose intolerance. J Clin Invest. 1985;75: 809-817.
10. Reaven GM. Banting Lecture 1988: role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
11. Marcus R, Krause L, Weder AB, et al. Sex-specific determinants of increased left ventricular mass in the Tecumseh Blood Pressure Study. Circulation. 1994;90:928-936.
12. Lind L, Andersson PE, Andren B, et al. Left ventricular hypertrophy in hypertension is associated with the insulin resistance metabolic syndrome. J Hypertens. 1995;13:433-438.
13. Paolisso G, Galzerano D, Gambardella A, et al. Left ventricular hypertrophy is associated with a stronger impairment of non-oxidative glucose metabolism in hypertensive patients. Eur J Clin Invest. 1995;25:529-533.
14. Paolisso G, Galderisi M, Tagliamonte MR, et al. Myocardial wall thickness and left ventricular geometry in hypertensives: relationship with insulin. Am J Hypertens. 1997;10:1250-1256.
15. Ohya Y, Abe I, Fujii K, et al. Hyperinsulinemia and left ventricular geometry in a work-site population in Japan. Hypertension. 1996;27: 729-734.
16. Andren B, Lind L, Hedenstierna G, et al. Left ventricular hypertrophy and geometry in a population sample of elderly males. Eur Heart J. 1996;17: 1800-1807.